Potassium Balance Disorders

Key Points

• Normal serum potassium is commonly 3.5 to 5.1 mEq/L; some references use a therapeutic window of 3.6 to 5.5 mEq/L.
• Hyperkalemia is potassium greater than 5.1 mEq/L and can progress to dysrhythmia or cardiac arrest.
• Hypokalemia is potassium less than 3.5 mEq/L and often presents with weakness, lethargy, and weak pulse findings.
• Severe escalation thresholds include potassium below about 3.0 mEq/L or above about 6.0 mEq/L, especially with ECG change.
• Hyperkalemia treatment often includes potassium binding, insulin plus dextrose, and temporary cardiac stabilization with IV calcium gluconate in severe presentations.
• IV potassium administration requires hydration, adequate renal function, infusion pump control, and strict avoidance of IV push.

Pathophysiology

Potassium is the most abundant intracellular electrolyte and is essential for cardiac rhythm, neuromuscular function, and cellular excitability. Potassium distribution is maintained by active transport through the sodium-potassium pump, and total potassium balance is strongly influenced by renal handling and aldosterone effects.

Hyperkalemia raises risk for electrical instability in the myocardium. Hypokalemia decreases membrane excitability and contributes to muscle and cardiovascular dysfunction. Because both states can cause serious cardiac effects, trend-based assessment and rapid intervention are core nursing priorities.

Classification

• Hyperkalemia: Serum potassium greater than 5.1 mEq/L; cues include irritability, GI cramping, diarrhea, and peaked T waves.
• Hypokalemia: Serum potassium less than 3.5 mEq/L; cues include muscle weakness, lethargy, and thready pulse.

Nursing Assessment

NCLEX Focus

Prioritize ECG changes, renal clearance status, and current potassium trend before initiating or advancing replacement.

• Trend serial serum-potassium values and correlate with symptom progression.
• Monitor ECG for hyperkalemia progression: shortened QT, peaked T waves, reduced or absent P-wave visibility, PR prolongation, QRS widening, junctional brady patterns, and asystole risk.
• Assess for weakness, lethargy, and pulse quality changes in hypokalemia.
• Monitor for hypokalemia-related ECG changes such as flattened or inverted T waves, U waves, and ST-segment depression.
• Confirm urine output and renal status before potassium replacement because potassium is renally excreted.
• Review causes including vomiting, gastric suctioning, diarrhea, potassium-wasting diuretics, beta-2 agonists, metabolic-acidosis, renal failure, aldosterone deficit, and potassium supplement exposure.
• In hyperglycemic crises, interpret potassium cautiously because apparent serum elevation can coexist with total-body potassium depletion (for example during diabetic ketoacidosis).
• Correlate unexpected severe hyperkalemia values with bedside findings and repeat specimen collection when pseudohyperkalemia is suspected (tourniquet time, fist clenching, hemolysis risk during draw).

Nursing Interventions

• Escalate severe hyperkalemia findings promptly due to risk for life-threatening systematic-ecg-interpretation-and-dysrhythmia-triage.
• For mild hyperkalemia, support medication and intake adjustments as ordered.
• For severe hyperkalemia, support ordered therapies such as potassium binding therapy, insulin with IV dextrose, IV calcium gluconate for temporary cardiac membrane stabilization, and dialysis-level escalation.
• When potassium-binding resins are used, monitor for repeated loose stools and protect skin integrity with prompt hygiene and barrier care.
• For hypokalemia, implement ordered oral or IV potassium replacement with strict infusion safeguards.
• For IV potassium replacement, prefer central-line delivery when available; if peripheral infusion is required, use a large high-flow vein and monitor site tolerance closely.
• Keep peripheral IV potassium concentration at or below 40 mEq/L and infusion rate at or below 20 mEq/hr; never give IV push or bolus potassium.
• Monitor IV insertion sites closely during potassium infusion and stop infusion immediately if infiltration or extravasation is suspected due to tissue-necrosis risk.
• Require two-RN independent verification of IV potassium dose and pump settings before infusion.
• Place patient on continuous bedside cardiac monitoring before and during IV potassium infusion.
• Recheck post-treatment potassium levels from a different line than infusion access.
• Use added caution when replacing potassium in clients taking ACE inhibitors, ARBs, or potassium-sparing diuretics because rebound hyperkalemia risk increases.

IV Potassium Safety

Potassium must never be administered IV push. Verify hydration and renal function first, use a pump, keep peripheral concentration at or below 40 mEq/L, and do not exceed 20 mEq/hr.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
Potassium Balance Disorders (cation-exchange-resin)	Sodium polystyrene (Kayexalate)	Used for severe hyperkalemia to bind potassium in the GI tract for excretion.
Potassium Balance Disorders (potassium-supplements)	Oral or IV potassium replacement	Confirm urine output before administration and follow infusion safety limits.
diuretics	Potassium-sparing or potassium-wasting agents	Diuretic type can raise or lower potassium and should be reviewed during cause analysis.

Clinical Judgment Application

Clinical Scenario

A patient with poor urine output develops potassium of 5.2 mEq/L with new ECG changes.

• Recognize Cues: Potassium is above 5.1 mEq/L and rhythm risk markers are present.
• Analyze Cues: Hyperkalemia with reduced renal clearance is likely driving electrical instability.
• Prioritize Hypotheses: Immediate risk is progression to life-threatening dysrhythmia.
• Generate Solutions: Escalate care, initiate ordered potassium-lowering treatment, and intensify monitoring.
• Take Action: Implement urgent protocol and coordinate repeat labs and ECG reassessment.
• Evaluate Outcomes: Potassium falls toward normal and rhythm stabilizes.

Related Concepts

• serum-potassium - Primary laboratory marker for diagnosis and treatment response.
• Potassium Balance Disorders - High potassium state with major cardiac risk.
• Potassium Balance Disorders - Low potassium state with neuromuscular and cardiovascular effects.
• systematic-ecg-interpretation-and-dysrhythmia-triage - Essential tool for detecting potassium-related conduction changes.
• kidney-disease - Renal clearance determines risk during replacement and correction.

Self-Check

1. Which ECG finding in hyperkalemia indicates urgent cardiac risk?
2. Why must urine output be confirmed before giving potassium replacement?
3. What infusion limit improves IV potassium safety?